Cite Filings / XERS
Feed Companies Filings Check
Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
Filings Financials Insiders Search text
All 346 Financials 79 Shareholder Meetings 5 Executive Compensation 68 Insider Trading 178 Beneficial Ownership Interest 18 Business Combinations 62 Public Offerings 19 Mutual Funds and ETFs 5 Others 48
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-23
  3. DEF 14A Proxy Proxy Statement 2025-04-23
  4. DEF 14A Proxy Proxy Statement 2024-04-23
  5. DEF 14A Proxy Proxy Statement 2023-04-26
  6. DEF 14A Proxy Proxy Statement 2022-04-28

Page 1 of 1 · 5 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…